Using a digital health tool to help people with opioid use disorder
Real World Adoption of an OUD Digital Health Therapeutic
This study is testing a new digital tool called KIOS that helps people with opioid use disorder by tracking their cravings, mood, and pain, and giving them personalized support to improve their recovery and overall well-being.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biomedical Development Corporation NIH-funded |
| Lab location | 1 site (Lexington, UNITED STATES) |
| Project ID | NIH-10741217 on NIH RePORTER |
What this research studies
This research focuses on the development and evaluation of KIOS, a digital health therapeutic designed to assist individuals suffering from opioid use disorder (OUD). The platform utilizes nonlinear control theory to track various symptoms such as cravings, mood, and pain, providing personalized feedback and intervention strategies tailored to each patient's unique recovery journey. By integrating medication-assisted treatment with behavioral therapy, KIOS aims to improve access to effective care and enhance the overall quality of life for patients. The study will assess how well this innovative tool can support patients in managing their condition and achieving better health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 12 and older who are struggling with opioid use disorder.
Not a fit: Patients who do not have opioid use disorder or those who are not seeking treatment for substance use issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a personalized digital tool that significantly improves recovery outcomes for individuals with opioid use disorder.
How similar studies have performed: Previous research has shown promise in using digital health tools for substance use disorders, indicating potential for success with this novel approach.
Where this research is happening
Lexington, UNITED STATES
- Biomedical Development Corporation — Lexington, United States (Active)
Researchers
- Principal investigator: Siegel, Gregg — Biomedical Development Corporation
- Study coordinator: Siegel, Gregg
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.